Atlas Trials

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Clinical trial NCT05950464 · RECRUITING

Trial details

NCT number
NCT05950464
Sponsor
National Cancer Institute (NCI)
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid AdenocarcinomaRecurrent Endometrial Low Grade Endometrioid AdenocarcinomaRecurrent Ovarian Clear Cell AdenocarcinomaRecurrent Ovarian Endometrioid AdenocarcinomaRecurrent Ovarian High Grade Serous AdenocarcinomaRecurrent Ovarian Low Grade Endometrioid AdenocarcinomaRecurrent Platinum-Resistant Ovarian Carcinoma
Start date
2023-12-18
Primary completion
2027-06-30
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.